The process behind the expression of mdr-1/P-gp and mrplMRP in human leukeinia/lymphoma

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1073-1078

  Hirose, Masao ^a,b  

^a NARUTO UNIVERSITY OF EDUCATION   (Japan)

^b NONE   (Japan)

Author keywords

Correlation; Expression; Leukemia; MRP; P gp

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; GENOTYPE; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; LYMPHOMA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 64949150551     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hirose M, Hosoi E, Hamano S and Jalili A: Multidrug resistance in hematological malignancy. J Med Invest 50: 126-135, 2003.
2. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM and Pastan I: Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265-269, 1987.
3. Van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PAW, Pieters R, Lowenberg B and Sonnevelt P: MDR-1 is an independent prognostic factor for response and survival in de novo acute myeloid leukemia. Br J Haematol 99: 76-83, 1997.
4. Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McCbnnell TS, Head DR, Weick J, Grever MR, Appelbaum FR and Willman CL: Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/Pglycoprotein, MRP1, and LRP in acute myeloid leukemia. Southwest Oncology Group Study. Blood 94: 1086-1099, 1999.
5. Schaich M, Soucek S, Thiede C, Ehninger G and Illmer T; SHG AML96 Study Group: MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. Br J Haematol 128: 324-332, 2005.
6. van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R and Sonneveld P: Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia 16: 833-839, 2002.
7. Tsimberidou AM, Paterakis G, Androutsos G, Anagnostopoulos N, Galanopoulos A, Kalmantis T, Meletis J, Rombos Y, Sagriotis A, Symeonidis A, Tiniakou M, Zoumbos N and Yataganas X: Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia. Leuk Res 26: 143-154, 2002.
8. den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ and Veerman AJ: Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood 91: 2092-2098, 1998.
9. Rosenberg MF, Mao Q, Holzenberg A, Ford RC, Deely RG and Cole SP: The structure of the multidrug resistance protein1 (MRP1/ABCC1). J Biol Chem 276: 16076-16082, 2001.
10. Lozzio CB and Lozzio BB: Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45: 321-334, 1975.
11. Collins SJ, Gallo RC and Gallagher RE: Continuous growth and differentiation of human myeloid leukemia cells in suspension culture. Nature 270: 347-349, 1977.
12. Hirose M, Takeda E, Ninomiya T, Kuroda Y and Miyao M: Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukemia and lymphoma cell lines. Brit J Cancer 56: 413-417, 1987.
13. Hirose M, Minato K, Tobinai K, Watanabe S, Shimoyama M, Abe T and Hinuma Y: Two novel cultured cell lines, A3/kawakami and A4/fukuda, derived from malignant lymphoma of B (non-T)-cell nature of the gastrointestinal tract. Gann (Jpn J Cancer Res) 74: 106-115, 1981.
14. Saji F and Tanigaki N: A human thy-l-like antigen expressed on cultured leukemic T-cells. Immunogenetics 15: 551-563, 1982.
15. Hirose M, Fukuzawa K and Kuroda Y: Vincristine resistant HL-60 cells show cross-resistance to hypoxanthine-xanthine oxidase. Cancer Letters 102: 217-221, 1996.
16. Hirose M, Hamano S, Tobinai K and Kuroda Y: Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression oh HLA class 1, ICAM-1, and CD20 in vincristine-resistant hematologic cell lines. J Immunother 22: 237-244, 1999.
17. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidine thiocyanate-chloroform extraction. Anal Biochem 162: 156-159, 1987.
18. Noonan KE, Beck C, Holmayer TA, Chin JE, Wunder JS, Andruis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD and Roninson IB: Quantitative analysis of MDR-1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990.
19. Abbaszadegan MR, Futscher BW, Klimecki WT, List A and Dalton WS: Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematologic cells. Cancer Res 54: 4676-4679, 1994.
20. Scheffer GL, Wijingaard OLJ, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJLM, Clevers HC and Scheper RJ: The drug resistance related protein LRP is the human major vault protein. Nat Med 1: 578-582, 1995.
21. Kourtri M, Vavatsi N, Gombakis N, Sidi V, Tzimagiorgis G, papageorgiou T, Koliouskas D and Athanassiadou F: Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. Int J hematol 86: 166-173, 2007.
22. van den Heuvel-Eibrink MM, van der Holt B, Boekhorst PAW, Pieters R, Lowenberg B and Sonnevelt P: CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. Ann Hematol 86: 329-337, 2007.